background

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep

Welcome to Dwaey, specifically on Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep page.
This medicine contains important and useful components, as it consists of
Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep is available in the market in concentration.

Generic Name of Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep - Learn More

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Precaution - What You Need to Know

Before using Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation, it is essential to consult your healthcare provider to ensure it is suitable for your condition. This medication is intended for topical use only (eye and ear applications) and should not be ingested. The use of this drug may cause local irritation, such as redness, itching, or burning, especially in the eye or ear. If these symptoms worsen or persist, you should stop using the medication and contact your healthcare provider. Prolonged use may lead to secondary infections due to overgrowth of non-susceptible organisms like fungi. If a secondary infection occurs, seek medical advice. Avoid using this combination product if you have a known allergy to any of its components, particularly Oxytetracycline or Polymixin B. Consult your doctor if you are pregnant or breastfeeding, as the safety of this combination in such cases has not been fully established.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Indication - Uses and Benefits

Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation is primarily used for the treatment of bacterial infections in the eyes and ears. This combination medication is effective in managing:
- Ophthalmic Infections: Such as conjunctivitis (pink eye), blepharitis, and other eye infections caused by susceptible bacteria.
- Otitis Externa: Infection or inflammation of the outer ear canal, often referred to as swimmer's ear.
- Bacterial Keratitis: Infection of the cornea.
- Trachoma: An eye infection caused by *Chlamydia trachomatis* that can lead to blindness if untreated.
The combination of Oxytetracycline (an antibiotic) and Polymixin B (a polymyxin class antibiotic) works to eliminate bacterial infections by inhibiting bacterial protein synthesis and disrupting bacterial cell membrane integrity.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Contraindications - Important Warnings

Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation should not be used in the following situations:
- Hypersensitivity: Contraindicated in patients with known hypersensitivity or allergy to Oxytetracycline, Polymixin B, or any other components of the formulation.
- Corneal Ulcers: It should not be used in patients with corneal ulcers, as the presence of Oxytetracycline could potentially exacerbate the condition.
- Open Wounds or Burns: It should not be applied to open or severe wounds unless directed by a healthcare provider.
- Severe Hearing Loss: Individuals with a history of ear damage or hearing impairment should use caution, as Polymixin B may contribute to ototoxicity (damage to the ear).

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Side Effects - What to Expect

Common side effects of Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation include:
- Eye: Temporary irritation, redness, itching, or burning sensation upon application. These symptoms typically resolve on their own.
- Ear: Localized irritation, itching, or a mild burning sensation in the ear.
- Photosensitivity: Although primarily a concern with systemic use, patients should still be cautious when applying this medication near the eyes or ears, as it can cause mild sensitivity to light in rare cases.

Severe side effects are uncommon but may include:
- Severe Allergic Reactions: Rash, swelling (especially around the eyes or ears), severe dizziness, or trouble breathing. These symptoms require immediate medical attention.
- Ototoxicity: Prolonged use or misuse in the ear may cause damage to hearing in rare instances, especially when combined with other ototoxic agents.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Mode of Action - How It Works

Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation works through a combination of two mechanisms:
- Oxytetracycline: A tetracycline antibiotic, inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA from attaching to the ribosome, thereby halting protein production. This action disrupts bacterial growth and replication.
- Polymixin B Sulphate: A polymyxin antibiotic that disrupts the bacterial cell membrane by binding to phospholipids, leading to cell membrane destabilization and leakage of essential cellular contents, ultimately killing the bacteria.

Together, these two antibiotics provide broad-spectrum antibacterial coverage for both Gram-positive and Gram-negative bacteria, making the combination effective for treating a wide variety of infections in the eyes and ears.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Drug Interactions - What to Avoid

While Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation is applied topically, it is still important to consider the following interactions:
- Other Topical Antibacterial Agents: Concurrent use with other antibacterial eye or ear medications may reduce the overall effectiveness of either treatment. Always consult with your healthcare provider if you are using multiple topical medications.
- Systemic Antibiotics: While the topical form of Oxytetracycline and Polymixin B is unlikely to significantly interact with systemic antibiotics, it’s always a good idea to inform your healthcare provider about any medications you're taking.
- Ototoxic Drugs: Combining this eye/ear preparation with other ototoxic drugs (such as certain diuretics or aminoglycoside antibiotics) may increase the risk of hearing damage, especially with prolonged use.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Adult Dose - Recommended Dosage

For adults, the typical dosage for Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation is as follows:
- Eye: Instill 1–2 drops into the affected eye(s) every 4–6 hours, or as prescribed by your healthcare provider.
- Ear: Instill 3–4 drops into the affected ear(s) 2–3 times a day, or as directed by your healthcare provider.
Follow the healthcare provider’s instructions for duration of treatment, and do not exceed the recommended dose to avoid adverse effects or resistance.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Child Dose - Dosage for Children

The use of Oxytetracycline 0.5% + Polymixin B Sulphate Eye and Ear Preparation in children should be done with caution, particularly for young children. While the safety profile is generally favorable, the exact dosage and frequency should be determined by a healthcare provider based on the child’s age, condition, and response to treatment. Typically, the dosage is similar to that of adults, but the healthcare provider will adjust it as needed, ensuring the treatment is both effective and safe. Always consult a healthcare provider before using this medication in pediatric patients.

As always, patients should seek professional medical advice before starting this medication to ensure proper usage and minimize any potential risks.

Oxytetracycline 0.5% + Polymixin B Sulphate E&E prep Renal Dose - Dosage for Kidney Conditions

Topical Oxytetracycline 0.5% + Polymixin B Sulphate is generally considered safe for use in patients with renal impairment, as it is applied locally and systemic absorption is minimal. However, caution should be exercised in patients with severe renal dysfunction, and regular monitoring may be required. It is always advisable to consult your healthcare provider for specific recommendations if you have renal issues.

  • Ophthalmic Anti-bacterial products -
  • Aural Anti-bacterial preparations -
  • banner

    Report Error

    Please feel welcome to contact us with any price or medical error. Our team will receive any reports.

    Available as

    Not available in a medicine form yet